NCT05343377尚未招募不适用
Prospective, Multicenter Clinical Study of Accurate Stratification and Prognostic Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2022年6月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 72
- 试验地点
- 1
- 主要终点
- Assessing the accuracy of circulating free methylated EBV DNA in predicting 2-year PFS in patients with newly diagnosed ENKTCL
研究概览
简要总结
This study is a prospective, multicenter, open-label, single-arm clinical study. This study plans to enroll 72 newly diagnosed ENKTCL patients. The enrollment was completed in 2 years, and the follow-up was terminated in 4 years. To observe the accuracy of circulating free methylated EBV DNA in predicting 2-year PFS rate, 2-year OS rate, and CR rate in newly diagnosed ENKTCL patients; and to clarify the prognostic stratification ability of PINK-cpgE compared with PINK-E
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •newly diagnosed ENKTCL confirmed by pathological tissue, the diagnostic criteria refer to the 2016 WHO diagnostic criteria
- •Sign written informed consent and be able to comply with the visits and related procedures specified in the protocol
排除标准
- •The investigator believes that the subjects may have other factors that may affect the efficacy or safety evaluation of this study
研究组 & 干预措施
circulate free methylated EBV DNA predicts PFS rate in ENKTCL
Experimental
干预措施: circulate free methylated EBV DNA (Diagnostic Test)
结局指标
主要结局
Assessing the accuracy of circulating free methylated EBV DNA in predicting 2-year PFS in patients with newly diagnosed ENKTCL
时间窗: 2 years
次要结局
- To assess the accuracy of circulating free methylated EBV DNA in predicting 2-year OS and CR rates in newly diagnosed ENKTCL patients(2 years)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological MalignanciesMultiple MyelomaLymphomaNCT05536154The Affiliated People's Hospital of Ningbo University68
招募中
不适用
Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological MalignanciesHematological MalignancyNCT05510089The Affiliated People's Hospital of Ningbo University62
Unknown
不适用
Clinical Investigation Study of Safety and Performance of the Sentio System.Hearing Loss, ConductiveHearing Loss, UnilateralHearing Loss, MixedNCT05166265Oticon Medical51
招募中
3 期
Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in ChildrenDiffuse Intrinsic Pontine GliomaNCT04532229Biotech Pharmaceutical Co., Ltd.48
Unknown
不适用
Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory GlaucomaGlaucomaNCT03639870Glaukos Corporation65